BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 32499024)

  • 1. Left Ventricular Hypertrophy and Clinical Outcomes Over 5 Years After TAVR: An Analysis of the PARTNER Trials and Registries.
    Gonzales H; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
    JACC Cardiovasc Interv; 2020 Jun; 13(11):1329-1339. PubMed ID: 32499024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Ventricular Hypertrophy Does Not Affect 1-Year Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Varshney AS; Manandhar P; Vemulapalli S; Kirtane AJ; Mathew V; Shah B; Lowenstern A; Kosinski AS; Kaneko T; Thourani VH; Bhatt DL
    JACC Cardiovasc Interv; 2019 Feb; 12(4):373-382. PubMed ID: 30784643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of Left Ventricular Mass After Transcatheter Aortic Valve Replacement: The PARTNER Trials and Registries.
    Chau KH; Douglas PS; Pibarot P; Hahn RT; Khalique OK; Jaber WA; Cremer P; Weissman NJ; Asch FM; Zhang Y; Gertz ZM; Elmariah S; Clavel MA; Thourani VH; Daubert M; Alu MC; Leon MB; Lindman BR
    J Am Coll Cardiol; 2020 May; 75(19):2446-2458. PubMed ID: 32408979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-Defined Prosthesis-Patient Mismatch Downgrades Frequency and Severity, and Demonstrates No Association With Adverse Outcomes After Transcatheter Aortic Valve Replacement.
    Mooney J; Sellers SL; Blanke P; Pibarot P; Hahn RT; Dvir D; Douglas PS; Weissman NJ; Kodali SK; Thourani VH; Jilaihawi H; Khalique O; Smith CR; Kueh SH; Ohana M; Grover R; Naoum C; Crowley A; Jaber WA; Alu MC; Parvataneni R; Mack M; Webb JG; Leon MB; Leipsic JA
    JACC Cardiovasc Interv; 2017 Aug; 10(15):1578-1587. PubMed ID: 28734891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry.
    Yoshijima N; Yanagisawa R; Hase H; Tanaka M; Tsuruta H; Shimizu H; Fukuda K; Naganuma T; Mizutani K; Araki M; Tada N; Yamanaka F; Shirai S; Tabata M; Ueno H; Takagi K; Higashimori A; Watanabe Y; Yamamoto M; Hayashida K;
    Catheter Cardiovasc Interv; 2020 Jan; 95(1):35-44. PubMed ID: 30977256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of Left Ventricular Diastolic Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement.
    Asami M; Lanz J; Stortecky S; Räber L; Franzone A; Heg D; Hunziker L; Roost E; Siontis GC; Valgimigli M; Windecker S; Pilgrim T
    JACC Cardiovasc Interv; 2018 Mar; 11(6):593-601. PubMed ID: 29501544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transapical Transcatheter Aortic Valve Replacement Is Associated With Increased Cardiac Mortality in Patients With Left Ventricular Dysfunction: Insights From the PARTNER I Trial.
    Elmariah S; Fearon WF; Inglessis I; Vlahakes GJ; Lindman BR; Alu MC; Crowley A; Kodali S; Leon MB; Svensson L; Pibarot P; Hahn RT; Thourani VH; Palacios IF; Miller DC; Douglas PS; Passeri JJ;
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2414-2422. PubMed ID: 29217004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
    Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
    JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early regression of severe left ventricular hypertrophy after transcatheter aortic valve replacement is associated with decreased hospitalizations.
    Lindman BR; Stewart WJ; Pibarot P; Hahn RT; Otto CM; Xu K; Devereux RB; Weissman NJ; Enriquez-Sarano M; Szeto WY; Makkar R; Miller DC; Lerakis S; Kapadia S; Bowers B; Greason KL; McAndrew TC; Lei Y; Leon MB; Douglas PS
    JACC Cardiovasc Interv; 2014 Jun; 7(6):662-73. PubMed ID: 24947722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversibility of Cardiac Function Predicts Outcome After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis.
    Sato K; Kumar A; Jones BM; Mick SL; Krishnaswamy A; Grimm RA; Desai MY; Griffin BP; Rodriguez LL; Kapadia SR; Obuchowski NA; Popović ZB
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28698259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-Year Clinical Outcomes in Women After Transcatheter Aortic Valve Replacement: Results From the First WIN-TAVI Registry.
    Chieffo A; Petronio AS; Mehilli J; Chandrasekhar J; Sartori S; Lefèvre T; Presbitero P; Capranzano P; Tchetche D; Iadanza A; Sardella G; Van Mieghem NM; Meliga E; Dumonteil N; Fraccaro C; Trabattoni D; Mikhail G; Sharma S; Ferrer MC; Naber C; Kievit P; Baber U; Snyder C; Sharma M; Morice MC; Mehran R;
    JACC Cardiovasc Interv; 2018 Jan; 11(1):1-12. PubMed ID: 29301640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of preprocedural left ventricle hypertrophy and geometrical patterns on mortality following TAVR.
    Rozenbaum Z; Finkelstein A; Zhitomirsky S; Topilsky Y; Halkin A; Banai S; Bazan S; Barbash I; Segev A; Guetta V; Danenberg H; Planner D; Orvin K; Assa HV; Assali A; Kornowski R; Steinvil A
    Am Heart J; 2020 Feb; 220():184-191. PubMed ID: 31862472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Pressure and Arterial Load After Transcatheter Aortic Valve Replacement for Aortic Stenosis.
    Lindman BR; Otto CM; Douglas PS; Hahn RT; Elmariah S; Weissman NJ; Stewart WJ; Ayele GM; Zhang F; Zajarias A; Maniar HS; Jilaihawi H; Blackstone E; Chinnakondepalli KM; Tuzcu EM; Leon MB; Pibarot P
    Circ Cardiovasc Imaging; 2017 Jul; 10(7):. PubMed ID: 28701528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of SAPIEN 3 Transcatheter Valve Implantation on Health Status in Patients With Severe Aortic Stenosis at Intermediate Surgical Risk: Results From the PARTNER S3i Trial.
    Baron SJ; Thourani VH; Kodali S; Arnold SV; Wang K; Magnuson EA; Pichard AD; Babaliaros V; George I; Miller DC; Tuzcu EM; Greason K; Herrmann HC; Smith CR; Leon MB; Cohen DJ;
    JACC Cardiovasc Interv; 2018 Jun; 11(12):1188-1198. PubMed ID: 29860075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic impact of left ventricular mass regression after transcatheter aortic valve replacement in patients with left ventricular hypertrophy.
    Oh JK; Lee SH; Lee SA; Kang DY; Lee S; Kim HJ; Ahn JM; Kim JB; Park DW; Song JM; Choo SJ; Kang DH; Song JK; Park SJ; Kim DH
    Int J Cardiol; 2021 Jun; 332():60-66. PubMed ID: 33781852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Patients with Low-Gradient Aortic Stenosis Undergoing Transcatheter or Surgical Aortic Valve Replacement.
    Kugelman N; Jaffe R; Aronson D; Sharoni E; Adawi S; Khader N; Shiran A
    Cardiovasc Revasc Med; 2020 Mar; 21(3):257-262. PubMed ID: 31103371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of transcatheter aortic valve replacement on left ventricular hypertrophy, diastolic dysfunction and quality of life in patients with preserved left ventricular function.
    Dahiya G; Kyvernitakis A; Joshi AA; Lasorda DM; Bailey SH; Raina A; Biederman RWW; Kanwar MK
    Int J Cardiovasc Imaging; 2021 Feb; 37(2):485-492. PubMed ID: 32902782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
    Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Diastolic Dysfunction and Health Status Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
    Malik AO; Omer M; Pflederer MC; Almomani A; Gosch KL; Jones PG; Peri-Okonny PA; Al Badarin F; Brandt HA; Arnold SV; Main ML; Cohen DJ; Spertus JA; Chhatriwalla AK
    JACC Cardiovasc Interv; 2019 Dec; 12(24):2476-2484. PubMed ID: 31786216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.